Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1289973 | 0.98 | LMNA (0.37) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| Bromide SCHEMBL29450513 | 0.98 | LMNA (0.37) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| Trifluoroacetic Acid SCHEMBL1289960 | 0.91 | MMP2 (0.35) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| Sulfuric Acid SCHEMBL1289861 | 0.91 | CA1 (0.36) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| SCHEMBL26324598 | 0.81 | CACNA1H (0.33) | CACNA1H | |
| SCHEMBL1751431 | 0.81 | KDM4E (0.40) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| SCHEMBL15607826 | 0.81 | CACNA1H (0.33) | CACNA1H | |
| SCHEMBL2035994 | 0.80 | KDM4E (0.39) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| Hydrochloric Acid SCHEMBL15792471 | 0.79 | KDM4E (0.39) | LMNAPOLBLOXL2SMN1; SMN2KDM4E | |
| SCHEMBL18293043 | 0.79 | CA1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214950-A1 | METHOD FOR PREPARING FLURALANER | HANGZHOU NORMAL UNIVERSITY (CN) | 2025-07-03 | — | — | US | claimed |
| US-12065414-B2 | Process for preparation of isoxazoline substituted benzamide compound | ZYDUS LIFESCIENCES LIMITED (IN) | 2024-08-20 | — | — | US | claimed |
| CN-114414678-B | Analysis method of related impurities of isoxazoline veterinary drug intermediate ammonium salt | 丽珠集团新北江制药股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115536541-A | Synthesis method of common intermediate of flurradine and afurane | 湖北美天生物科技股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-113461653-B | Method for preparing fraxidin intermediate, and preparation intermediate and application thereof | 洛阳惠中兽药有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-114414678-A | Analysis method for related impurities of isoxazoline veterinary drug intermediate ammonium salt | 丽珠集团新北江制药股份有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-114315748-A | Synthesis method of flurarana | 江苏天和制药有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20220064130-A1 | PROCESS FOR PREPARATION OF ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND | ZYDUS LIFESCIENCES LIMITED (IN) | 2022-03-03 | — | — | US | claimed |
| CN-113896690-A | Preparation method of isoxazoline anthelmintic agent fluranide | 常州齐晖药业有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-113651765-A | Synthesis of afurana | 江苏君若药业有限公司 | 2021-11-16 | — | — | CN | claimed |
| EP-2470007-A2 | FOAMABLE PESTICIDE COMPOSITIONS AND METHODS OF APPLICATION | BASF Corporation (US) | 2012-07-04 | — | — | EP | claimed |
| WO-2012084670-A1 | PESTICIDAL ACTIVE MIXTURES COMPRISING PYRAZOLE COMPOUNDS | BASF SE (DE) | 2012-06-28 | — | — | WO | claimed |
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | BASF CORPORATION (US) | 2012-06-14 | — | — | US | claimed |
| JP-4805909-B2 | — | — | 2011-11-02 | — | — | JP | claimed |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| WO-2010129345-A2 | FOAMABLE PESTICIDE COMPOSITIONS | BASF CORPORATION (US) | 2010-11-11 | — | — | WO | claimed |
| WO-2010127019-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF CORPORATION (US) | 2010-11-04 | — | — | WO | claimed |
| WO-2010070068-A2 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-06-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | DDT, PLD1, ACHE | LMNA 409/4885POLB 3106/4885LOXL2 778/4885 |
| US-12065414-B2 | Process for preparation of isoxazoline substituted benzamide compound | CYP3A7, CYP3A4, CYP4X1 | LMNA 2145/4885POLB 1127/4885LOXL2 2737/4885 |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | DDT, PON1, ACHE | LMNA 2319/4885POLB 4588/4885LOXL2 1300/4885 |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | DDT, ACHE, PON1 | LMNA 1606/4885POLB 4662/4885LOXL2 997/4885 |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | DDT, ACHE, CHRM2 | LMNA 3123/4885POLB 4409/4885LOXL2 3630/4885 |
| US-20220064130-A1 | PROCESS FOR PREPARATION OF ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND | CYP3A7, CYP3A4, CYP4X1 | LMNA 2145/4885POLB 1127/4885LOXL2 2737/4885 |
| US-20250214950-A1 | METHOD FOR PREPARING FLURALANER | FFAR4, FFAR2, CYP2A13 | LMNA 1256/4885POLB 2057/4885LOXL2 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.